Opioid treatment maker accused of monopoly - Titusville Herald: Business

Opioid treatment maker accused of monopoly

Print
Font Size:
Default font size
Larger font size

Posted: Friday, September 23, 2016 12:35 am

Herald

HARRISBURG — Pennsylvania Attorney General Bruce R. Beemer and 35 other attorneys general on Thursday filed an antitrust lawsuit against the makers of Suboxone, a prescription drug used to treat opioid addiction, over allegations that the companies engaged in a scheme to block generic competitors and cause purchasers to pay artificially high prices.

Reckitt Benckiser Pharmaceuticals and Indivior are accused of conspiring with MonoSol Rx to switch Suboxone from a tablet version to a film (that dissolves in the mouth) in order to prevent or delay generic alternatives and maintain monopoly profits.

The companies are accused of violating state and federal antitrust laws.

“The alleged scheme the defendants utilized denied consumers the choice of a generic version of Suboxone,” Beemer said. “This conduct forced consumers to pay more for Suboxone and severely limited their options for treating their opioid addictions.”

Suboxone is a brand-name prescription drug used to treat heroin addiction and other opioid addictions by easing addiction cravings. No generic alternative tablet is currently available.

According to the lawsuit, when Reckitt introduced Suboxone in 2002 (in tablet form), it had exclusivity protection that lasted for seven years, meaning no generic tablet version could enter the market during that time. Before that period ended, however, Reckitt worked with MonoSol to create a new version of Suboxone — a dissolvable film, similar in size to a breath strip.

Over time, Reckitt allegedly converted the market away from the tablet to the film through marketing, price adjustments and other methods. Ultimately, after the majority of Suboxone prescriptions were written for the film, Reckitt removed the Suboxone tablet from the United States market.

The attorneys general allege this conduct was illegal “product hopping,” where a company makes modest changes to its product to extend patent protections so other companies can’t enter the market and offer cheaper generic alternatives. According to the suit, the Suboxone film provided no real benefit over the tablet and Reckitt continued to sell the tablets in other countries even after removing them from the U.S. market. Reckitt also allegedly expressed unfounded safety concerns about the tablet version and intentionally delayed FDA approval of generic versions of Suboxone.

As a result, the attorneys general allege that consumers and purchasers have paid artificially high monopoly prices since late 2009, when generic alternatives of Suboxone tablets might otherwise have become available. During that time, annual sales of Suboxone topped $1 billion.

The lawsuit, filed in the U.S. District Court for the Eastern Division of Pennsylvania, accuses the companies of violating the federal Sherman Act and state antitrust laws, including the Unfair Trade Practices and Consumer Protection Law and common law. Counts include monopolization and illegal restraint of trade. In the suit, the attorneys general ask the court to stop the companies from engaging in anticompetitive conduct, to restore competition and to order appropriate relief for consumers and the states, plus costs and fees.

Other states and territories joining the lawsuit are Alabama, Alaska, Arkansas, California, Colorado, District of Columbia, Connecticut, Delaware, Florida, Hawaii, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New York, North Carolina, Ohio, Oklahoma, Rhode Island, South Carolina, Tennessee, Utah, Vermont, Virginia, Washington and Wisconsin.

Rules of Conduct

  • 1 Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
  • 2 Don't Threaten or Abuse. Threats of harming another person will not be tolerated. AND PLEASE TURN OFF CAPS LOCK.
  • 3 Be Truthful. Don't knowingly lie about anyone or anything.
  • 4 Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
  • 5 Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
  • 6 Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Welcome to the discussion.

Titusville, PA

Current Conditions

Cloudy
48°
Humidity: 64%
Winds: WNW at 7mph
Feels Like: 45°

Your Extended Forecast

Tomorrow

weather
High 49°/Low 32°
Partly cloudy. Highs in the upper 40s and lows in the low 30s.

saturday

weather
High 60°/Low 43°
More sun than clouds. Highs in the low 60s and lows in the low 40s.

sunday

weather
High 66°/Low 43°
Mix of sun and clouds. Highs in the mid 60s and lows in the low 40s.

Featured Ads

Follow us on Facebook

E-Edition Information

E-edition subscription rates

The Titusville Herald’s complete on-line newspaper version (E-edition) requires a subscription.

Stocks